Related Experiment Video
Updated: Jun 15, 2026

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies
Anna Kagan1, David Sheikh-Hamad
1Medicine/Nephrology, Baylor College of Medicine, Houston, Texas 77030, USA.
Insights
Contrast-induced nephropathy (CIN) is a significant cause of acute kidney injury in hospitals. Prompt identification of at-risk patients and preventative measures are crucial for mitigating its severe outcomes.
Area of Science:
- Nephrology
- Radiology
- Internal Medicine
Background:
- Contrast-induced nephropathy (CIN) is a major cause of hospital-acquired acute kidney injury (AKI).
- CIN is linked to increased mortality, morbidity, and prolonged hospital stays.
- It is a predictable and potentially preventable condition.
Purpose of the Study:
- To review recent literature on CIN from a nephrologist's perspective.
- To focus on pathophysiology, at-risk populations, contrast agent impact, and prevention strategies for CIN.
Main Methods:
- Evidence-based literature review.
- Synthesis of recent studies on CIN.
- Expert nephrologist's perspective.
Main Results:
- CIN pathophysiology involves renal medullary hypoxia and direct toxicity.
- Certain patient populations (e.g., pre-existing renal disease, diabetes) are at higher risk.
- Different iodinated contrast agents may have varying nephrotoxic potentials.
Conclusions:
- CIN is a critical concern in hospitalized patients undergoing contrast procedures.
- Prophylactic strategies including hydration, N-acetylcysteine, and judicious contrast agent selection are key.
- Further research into optimal prevention remains essential.
Abstract:
Contrast-induced nephropathy, also known as contrast-induced acute kidney injury, is associated with rapid and often irreversible decline in kidney function following the administration of iodinated contrast agents. Contrast-induced nephropathy is the third leading cause of acute kidney injury in hospitalized patients, and substantially increases mortality, morbidity, and length of hospitalization. Contrast-induced nephropathy follows a predictable time of onset and is potentially preventable. It has been the subject of numerous studies addressing characteristics of the populations at risk and prophylactic strategies. This evidence-based review summarizes recent literature and provides a nephrologists' perspective on contrast-induced nephropathy, focusing on: the pathophysiology of contrast-induced nephropathy; identification of populations at risk; correlation between contrast-induced nephropathy and the type of contrast agent used; and finally, measures to prevent contrast-induced nephropathy, including intravenous fluids, sodium bicarbonate, N-acetylcysteine, and hemofiltration/hemodialysis.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
